XM
TEVA icon

XTX Markets’s Teva Pharmaceuticals TEVA Stock Holding History

XTX Markets’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$253K Buy
+26,209
New +$251K 0.52% 80

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

XTX Markets's TEVA Position: Q4 2020 in Review

XTX Markets opened a new position in Teva Pharmaceuticals (TEVA) in Q4 2020: 26,209 shares worth $253K. The stake represents 0.52% of the portfolio and ranks #80 among its holdings.

450 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.

  • XTX Markets held 26,209 shares of Teva Pharmaceuticals worth $253K as of Q4 2020.
  • Teva Pharmaceuticals was a new XTX Markets position in Q4 2020.
  • Teva Pharmaceuticals made up 0.52% of XTX Markets's portfolio in Q4 2020, its #80 holding.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2020.

Based on XTX Markets's 13F filing for Q4 2020, filed 25 Jan 2021.